• Tools to assess KalVista Pharmaceuticals Inc.’s risk profile - July 2025 Catalysts & Daily Risk Controlled Trade Plans newser.com Fri, 03 Oct 2025 08:57:03 GMT
• Is KalVista Pharmaceuticals Inc. forming a bottoming base - 2025 Fundamental Recap & Daily Stock Momentum Reports newser.com Fri, 03 Oct 2025 06:40:39 GMT
• Is KalVista Pharmaceuticals Inc. (4XC1) stock included in top ETFs - Market Sentiment Summary & Long-Term Safe Investment Ideas newser.com Fri, 03 Oct 2025 06:04:50 GMT
• Can momentum traders help lift KalVista Pharmaceuticals Inc. - July 2025 PreEarnings & Intraday High Probability Alerts newser.com Fri, 03 Oct 2025 04:37:03 GMT
• is kalvista pharmaceuticals inc. forming a bottoming base - july 2025 preearnings & verified swing trading watchlists newser.com Thu, 02 Oct 2025 23:47:20 GMT
• kalvista pharmaceuticals appoints bethany l. sensenig to board of directors citybiz Thu, 02 Oct 2025 14:12:28 GMT
• KalVista Pharmaceuticals Appoints Bethany Sensenig to Board TipRanks Thu, 02 Oct 2025 11:54:18 GMT
• KalVista Pharmaceuticals Announces Appointment of Bethany L. Sensenig to Board of Directors Business Wire Thu, 02 Oct 2025 11:00:00 GMT
• Is KalVista Pharmaceuticals Inc. (4XC1) stock included in top ETFs - Market Growth Summary & Breakout Confirmation Alerts newser.com Wed, 01 Oct 2025 09:40:43 GMT
• tools to assess kalvista pharmaceuticals inc.’s risk profile - 2025 market outlook & smart swing trading alerts newser.com Wed, 01 Oct 2025 01:02:30 GMT
• Tools to assess KalVista Pharmaceuticals Inc.’s risk profile - 2025 Trade Ideas & Smart Swing Trading Techniques newser.com Tue, 30 Sep 2025 09:48:34 GMT
• what drives kalvista pharmaceuticals inc 4xc1 stock price - earnings per share trends & affordable trading strategies earlytimes.in Tue, 30 Sep 2025 09:33:31 GMT
• can kalvista pharmaceuticals inc. stock sustain free cash flow growth - july 2025 highlights & weekly breakout opportunity watchli... newser.com Tue, 30 Sep 2025 08:40:58 GMT
• Is KalVista Pharmaceuticals Inc. (4XC1) stock included in top ETFs - Market Risk Analysis & Long-Term Safe Investment Ideas newser.com Tue, 30 Sep 2025 04:24:20 GMT
• Custom strategy builders for tracking KalVista Pharmaceuticals Inc. - 2025 Dividend Review & Breakout Confirmation Trade Signals newser.com Mon, 29 Sep 2025 22:04:32 GMT
• Is KalVista Pharmaceuticals Inc. (4XC1) stock included in top ETFs - 2025 EndofYear Setup & Community Consensus Stock Picks newser.com Mon, 29 Sep 2025 05:53:10 GMT
• With HAE Drug EKTERLY Off To A Strong Start, Is Now The Time To Keep An Eye On KalVista Stock? Nasdaq Sun, 28 Sep 2025 15:36:00 GMT
• what drives kalvista pharmaceuticals inc 4xc1 stock price - straddle and strangle trades & free superior stock performance Early Times Sun, 28 Sep 2025 12:09:49 GMT
• KalVista prices upsized offering of $125M of 3.250% notes due 2031 MSN Sun, 28 Sep 2025 04:35:54 GMT
• Can KalVista Pharmaceuticals Inc. stock sustain free cash flow growth - Weekly Trend Recap & AI Powered Trade Plan Recommendations... newser.com Sat, 27 Sep 2025 20:29:52 GMT
• what drives kalvista pharmaceuticals inc 4xc1 stock price - bear market strategies & stay safe with built-in risk monitoring Early Times Sat, 27 Sep 2025 00:38:05 GMT
• KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the 20th German Allergy Congress Business Wire Fri, 26 Sep 2025 11:00:00 GMT
• 6 new clinical studies: kalvista's ekterly® shows promise in hereditary angioedema treatment data Stock Titan Fri, 26 Sep 2025 11:00:00 GMT
• kalvista prices upsized offering of $125m of 3.250% notes due 2031 MSN Fri, 26 Sep 2025 04:41:40 GMT
• kalvista prices upsized offering of $125m of 3.250% notes due 2031 MSN Thu, 25 Sep 2025 17:23:56 GMT
• kalvista pharmaceuticals (nasdaq:kalv) shares down 6.9% - what's next? MarketBeat Thu, 25 Sep 2025 17:14:55 GMT
• ekterly approved as on-demand therapy for hae in eu, switzerland Angioedema News Thu, 25 Sep 2025 16:05:38 GMT
• kalvista pharma falls after $125 mln convertible debt sale TradingView Thu, 25 Sep 2025 12:16:26 GMT
• kalvista pharmaceuticals prices $125 million notes offering MarketScreener Thu, 25 Sep 2025 08:15:28 GMT
• KalVista prices $125 million convertible senior notes offering Investing.com Thu, 25 Sep 2025 03:15:01 GMT
• kalvista pharmaceuticals stock falls after convertible notes offering by investing.com Investing.com South Africa Thu, 25 Sep 2025 03:08:04 GMT
• KalVista Prices Upsized Offering of $125.0 Million of 3.250% Convertible Senior Notes Due 2031 Business Wire Thu, 25 Sep 2025 02:52:00 GMT
• kalvista plans to offer $110 million in convertible notes by investing.com Investing.com Australia Thu, 25 Sep 2025 00:02:59 GMT
• kalvista plans to offer $110 million in convertible notes Investing.com Wed, 24 Sep 2025 21:30:18 GMT
• kalvista (kalv) plans $110m convertible senior notes offering GuruFocus Wed, 24 Sep 2025 20:47:39 GMT
• kalvista pharmaceuticals proposes private offering of $110 million of convertible notes; shares fall after hours MarketScreener Wed, 24 Sep 2025 20:27:21 GMT
• kalvista pharma falls after announcing $110 mln convertible debt offering TradingView Wed, 24 Sep 2025 20:26:00 GMT
• Kalvista Pharmaceuticals stock falls after convertible notes offering Investing.com Wed, 24 Sep 2025 20:12:46 GMT
• KalVista Pharmaceuticals Announces Proposed Offering of $110.0 Million of Convertible Senior Notes Business Wire Wed, 24 Sep 2025 20:01:00 GMT
• kalvista pharmaceuticals experiences evaluation revision amidst mixed market signals Markets Mojo Wed, 24 Sep 2025 08:50:53 GMT
• hereditary angioedema market outlook 2034 – clinical trials, market size, medication, prevalence, companies by delveinsight Barchart.com Tue, 23 Sep 2025 22:44:06 GMT
• kalvista pharmaceuticals experiences evaluation revision amidst mixed market signals Markets Mojo Tue, 23 Sep 2025 00:11:11 GMT
• hereditary angioedema market dynamics indicate upward trajectory through 2034, reports delveinsight openPR.com Mon, 22 Sep 2025 12:38:49 GMT
• kalvista pharmaceuticals announces european commission and swissmedic approval of ekterly® (sebetralstat), first and only oral on-... BioSpace Mon, 22 Sep 2025 07:55:29 GMT
• decliners report: what analysts say about kalvista pharmaceuticals inc stock - july 2025 macro moves & scalable portfolio growth m... خودرو بانک Sun, 21 Sep 2025 04:22:41 GMT
• Analyzing KalVista Pharmaceuticals Inc. with risk reward ratio charts - 2025 Investor Takeaways & Daily Price Action Insights newser.com Fri, 19 Sep 2025 23:30:18 GMT
• earnings miss: can kalvista pharmaceuticals inc. deliver consistent dividends - july 2025 market mood & low risk profit maximizing... khodrobank.com Fri, 19 Sep 2025 18:02:44 GMT
• KalVista Pharmaceuticals’ Hereditary Angioedema Drug Approved In EU, Switzerland: Retail Sees Stock Rallying To $22 In A Year Stocktwits Fri, 19 Sep 2025 17:04:08 GMT
• kalvista (kalv) secures eu approval for hereditary angioedema tr GuruFocus Fri, 19 Sep 2025 14:07:16 GMT
• kalvista, ionis/sobi win eu nod for drugs (kalv:nasdaq) Seeking Alpha Fri, 19 Sep 2025 13:36:40 GMT
• gold miners, perpetua resources, kalvista pharmaceuticals TradingView Fri, 19 Sep 2025 13:05:37 GMT
• kalvista (kalv) gains european and swiss approval for ekterly GuruFocus Fri, 19 Sep 2025 11:56:19 GMT
• kalvista’s oral hae treatment ekterly receives eu and swiss approval Investing.com Fri, 19 Sep 2025 11:17:22 GMT
• first-ever oral hae attack treatment: kalvista's ekterly secures major eu & swiss regulatory win Stock Titan Fri, 19 Sep 2025 11:00:00 GMT
• KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY Business Wire Fri, 19 Sep 2025 07:00:00 GMT
• Stocks To Watch: KalVista Pharmaceuticals Sees Relative Strength Rating Jump To 83 Investor's Business Daily Fri, 19 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals, inc. (kalv) investor outlook: exploring a 128% upside potential DirectorsTalk Interviews Fri, 19 Sep 2025 07:00:00 GMT
• kalvista, ionis/sobi among latest to win eu nod for rare disease drugs Seeking Alpha Fri, 19 Sep 2025 07:00:00 GMT
• value recap: is kalvista pharmaceuticals inc impacted by rising rates - weekly risk summary & ai powered trade plan recommendation... khodrobank.com Fri, 19 Sep 2025 03:03:24 GMT
• kalvista pharmaceuticals, inc. (nasdaq:kalv) given average rating of "buy" by brokerages MarketBeat Thu, 18 Sep 2025 20:14:27 GMT
• kalvista pharmaceuticals, inc. (nasdaq:kalv) receives average recommendation of "buy" from analysts MarketBeat Thu, 18 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals’ hereditary angioedema drug approved in eu, switzerland: retail sees stock rallying to $22 in a year Stocktwits Thu, 18 Sep 2025 00:45:20 GMT
• kalvista pharmaceuticals’ hereditary angioedema drug approved in eu, switzerland: retail sees stock rallying to $22 in a year Stocktwits Wed, 17 Sep 2025 21:49:02 GMT
• support test: can kalvista pharmaceuticals inc expand its profit margins - market growth summary & low drawdown investment ideas خودرو بانک Wed, 17 Sep 2025 16:04:37 GMT
• kalvista pharmaceuticals' (kalv) "buy" rating reiterated at needham & company llc MarketBeat Wed, 17 Sep 2025 08:03:58 GMT
• jmp securities increases kalvista pharmaceuticals (nasdaq:kalv) price target to $28.00 MarketBeat Wed, 17 Sep 2025 07:47:01 GMT
• kalvista pharmaceuticals, inc. $kalv shares bought by woodline partners lp MarketBeat Wed, 17 Sep 2025 07:41:15 GMT
• KalVista Pharmaceuticals (NASDAQ:KALV) Stock Price Expected to Rise, JMP Securities Analyst Says MarketBeat Wed, 17 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals (nasdaq:kalv) given buy rating at needham & company llc MarketBeat Wed, 17 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals (nasdaq:kalv) trading down 4.4% following weak earnings MarketBeat Wed, 17 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals (nasdaq:kalv) releases quarterly earnings results, misses expectations by $0.21 eps MarketBeat Wed, 17 Sep 2025 00:00:00 GMT
• kalvista pharmaceuticals, inc. (nasdaq:kalv) given consensus recommendation of "buy" by analysts MarketBeat Tue, 16 Sep 2025 22:52:30 GMT
• market leaders: is kalvista pharmaceuticals inc. stock a falling knife or bargain buy - 2025 momentum check & target return focuse... خودرو بانک Tue, 16 Sep 2025 19:59:02 GMT
• growth value: what analysts say about kalvista pharmaceuticals inc stock - july 2025 selloffs & ai powered buy/sell recommendation... خودرو بانک Tue, 16 Sep 2025 19:52:41 GMT
• aug summary: will kalvista pharmaceuticals inc stock benefit from m a - price action & ai forecasted entry and exit points خودرو بانک Tue, 16 Sep 2025 17:11:12 GMT
• analysts offer insights on healthcare companies: abivax sa sponsored adr (abvx), kalvista pharmaceuticals (kalv) and argenx se (ar... The Globe and Mail Tue, 16 Sep 2025 13:02:00 GMT
• woodline partners lp has $18.67 million stock holdings in kalvista pharmaceuticals, inc. $kalv MarketBeat Tue, 16 Sep 2025 07:39:29 GMT
• KalVista Pharmaceuticals, Inc. $KALV Shares Bought by Woodline Partners LP MarketBeat Tue, 16 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals (nasdaq:kalv) releases quarterly earnings results, misses expectations by $0.21 eps MarketBeat Tue, 16 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals (nasdaq:kalv) shares gap up - here's why MarketBeat Tue, 16 Sep 2025 07:00:00 GMT
• analyst calls: is kalvista pharmaceuticals inc subject to activist investor interest - july 2025 earnings & real-time buy signal a... خودرو بانک Tue, 16 Sep 2025 04:15:23 GMT
• woodline partners lp raises holdings in kalvista pharmaceuticals, inc. $kalv MarketBeat Mon, 15 Sep 2025 09:27:06 GMT
• kalvista pharmaceuticals, inc. (nasdaq:kalv) receives average recommendation of "buy" from analysts MarketBeat Mon, 15 Sep 2025 06:19:48 GMT
• kalvista pharmaceuticals (nasdaq:kalv) ceo sells $115,536.96 in stock MarketBeat Sun, 14 Sep 2025 18:46:16 GMT
• kalvista pharmaceuticals (nasdaq:kalv) stock price down 4.4% after earnings miss MarketBeat Sun, 14 Sep 2025 14:20:14 GMT
• needham & company llc reiterates buy rating for kalvista pharmaceuticals (nasdaq:kalv) MarketBeat Sun, 14 Sep 2025 14:07:11 GMT
• kalvista pharmaceuticals (nasdaq:kalv) price target raised to $28.00 MarketBeat Sun, 14 Sep 2025 12:29:19 GMT
• benjamin palleiko sells 7,294 shares of kalvista pharmaceuticals (nasdaq:kalv) stock MarketBeat Sun, 14 Sep 2025 07:51:34 GMT
• insider selling: kalvista pharmaceuticals (nasdaq:kalv) ceo sells 7,294 shares of stock MarketBeat Sun, 14 Sep 2025 07:51:34 GMT
• benjamin l. palleiko sells 7,294 shares of kalvista pharmaceuticals (nasdaq:kalv) stock MarketBeat Sun, 14 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals (nasdaq:kalv) shares gap up - time to buy? MarketBeat Sat, 13 Sep 2025 15:01:09 GMT
• kalvista pharmaceuticals (nasdaq:kalv) announces earnings results MarketBeat Sat, 13 Sep 2025 13:14:00 GMT
• woodline partners lp boosts stake in kalvista pharmaceuticals, inc. $kalv MarketBeat Sat, 13 Sep 2025 09:45:30 GMT
• KalVista Pharmaceuticals (NASDAQ:KALV) Sets New 1-Year High - Here's What Happened MarketBeat Sat, 13 Sep 2025 07:00:00 GMT
• adage capital partners gp l.l.c. sells 24,000 shares of kalvista pharmaceuticals, inc. $kalv MarketBeat Sat, 13 Sep 2025 06:06:49 GMT
• a quick look at today's ratings for kalvista pharmaceuticals(kalv.us), with a forecast between $28 to $37 富途牛牛 Fri, 12 Sep 2025 15:06:52 GMT
• needham maintains kalvista pharmaceuticals(kalv.us) with buy rating, maintains target price $28 富途牛牛 Fri, 12 Sep 2025 13:33:00 GMT
• kalvista stock price target raised to $28 from $27 at jmp on strong ekterly demand Investing.com Fri, 12 Sep 2025 12:40:46 GMT
• KalVista Pharmaceuticals Jumps After EKTERLY’s FDA Approval Finimize Fri, 12 Sep 2025 12:26:23 GMT
• kalvista pharmaceuticals, inc. $kalv shares sold by adage capital partners gp l.l.c. MarketBeat Fri, 12 Sep 2025 10:57:43 GMT
• parkman healthcare partners llc buys shares of 753,752 kalvista pharmaceuticals, inc. $kalv MarketBeat Fri, 12 Sep 2025 09:52:00 GMT
• kalvista price target raised to $28 from $27 at citizens jmp TipRanks Fri, 12 Sep 2025 09:39:47 GMT
• KalVista Pharmaceuticals Inc (KALV) Q1 2026 Earnings Call Highlights: EKTERLY Launch Drives ... Yahoo Finance Fri, 12 Sep 2025 07:00:00 GMT
• KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) Q1 2026 Earnings Call Transcript Insider Monkey Fri, 12 Sep 2025 07:00:00 GMT
• KalVista reports strong sales in early launch of hereditary angioedema drug Endpoints News Fri, 12 Sep 2025 07:00:00 GMT
• Strong Initial Sales and Medical Endorsement Drive Buy Rating for KalVista Pharmaceuticals’ Ekterly TipRanks Fri, 12 Sep 2025 07:00:00 GMT
• Promising Launch of Ekterly Boosts KalVista Pharmaceuticals’ Market Potential TipRanks Fri, 12 Sep 2025 07:00:00 GMT
• KalVista Pharmaceuticals (KALV) Maintains 'Buy' Rating by Needha GuruFocus Fri, 12 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals (kalv) target price raised by jmp securities | kalv stock news GuruFocus Fri, 12 Sep 2025 07:00:00 GMT
• h.c. wainwright maintains kalvista pharmaceuticals(kalv.us) with buy rating, maintains target price $27 富途牛牛 Fri, 12 Sep 2025 07:00:00 GMT
• adage capital partners gp l.l.c. sells 24,000 shares of kalvista pharmaceuticals, inc. $kalv MarketBeat Fri, 12 Sep 2025 07:00:00 GMT
• jonestrading maintains kalvista pharmaceuticals(kalv.us) with buy rating, maintains target price $37 富途牛牛 Fri, 12 Sep 2025 06:57:40 GMT
• kalvista pharmaceuticals reports strong start for ekterly launch TipRanks Fri, 12 Sep 2025 03:56:04 GMT
• kalvista pharmaceuticals, inc. (kalv) reports q1 loss, lags revenue estimates sharewise.com Fri, 12 Sep 2025 02:18:02 GMT
• kalvista pharma earnings missed by $0.16, revenue topped estimates by investing.com Investing.com Australia Fri, 12 Sep 2025 01:38:03 GMT
• promising market penetration and growth potential for kalvista pharmaceuticals’ ekterly TipRanks Fri, 12 Sep 2025 01:32:27 GMT
• benjamin palleiko sells 7,294 shares of kalvista pharmaceuticals (nasdaq:kalv) stock MarketBeat Fri, 12 Sep 2025 01:13:34 GMT
• kalvista pharmaceuticals’ earnings call highlights ekterly success TipRanks Fri, 12 Sep 2025 00:05:54 GMT
• bofa securities maintains kalvista pharmaceuticals(kalv.us) with buy rating, cuts target price to $36 富途牛牛 Thu, 11 Sep 2025 23:37:46 GMT
• td cowen maintains kalvista pharmaceuticals(kalv.us) with buy rating, maintains target price $30 富途牛牛 Thu, 11 Sep 2025 22:48:31 GMT
• kalvista stock price target lowered to $36 by bofa on ekterly launch data Investing.com Thu, 11 Sep 2025 22:26:24 GMT
• kalvista pharmaceuticals, inc. $kalv shares bought by invesco ltd. MarketBeat Thu, 11 Sep 2025 17:00:50 GMT
• kalvista pharmaceuticals jumps after ekterly’s fda approval Finimize Thu, 11 Sep 2025 15:35:27 GMT
• kalvista pharmaceuticals q1 2026 earnings call transcript MarketBeat Thu, 11 Sep 2025 14:26:15 GMT
• kalvista pharmaceuticals, inc. reports earnings results for the first quarter ended july 31, 2025 MarketScreener Thu, 11 Sep 2025 13:36:33 GMT
• sector update: health care stocks flat to higher pre-bell thursday MarketScreener Thu, 11 Sep 2025 13:21:43 GMT
• kalvista pharmaceuticals, inc. (kalv) q1 fy2026 earnings call transcript Yahoo Finance Thu, 11 Sep 2025 12:30:00 GMT
• kalvista pharma earnings missed by $0.16, revenue topped estimates Investing.com Thu, 11 Sep 2025 11:22:30 GMT
• drug developer kalvista pharmaceuticals posts q1 revenue after new product launch MarketScreener Thu, 11 Sep 2025 11:16:12 GMT
• kalvista (kalv) sees strong demand following ekterly approval GuruFocus Thu, 11 Sep 2025 11:15:14 GMT
• about us - great american insurance group - specialty property & casualty insurance FinancialContent Thu, 11 Sep 2025 11:00:00 GMT
• KalVista Pharmaceuticals, Inc. (KALV) Reports Q1 Loss, Lags Revenue Estimates Yahoo Finance Thu, 11 Sep 2025 07:00:00 GMT
• KalVista Pharmaceuticals Provides Operational Update and Reports Fiscal Quarter Financial Results Business Wire Thu, 11 Sep 2025 07:00:00 GMT
• First-Ever Oral HAE Attack Treatment: KalVista's EKTERLY Gains FDA & UK Approval with Strong Early Adoption Stock Titan Thu, 11 Sep 2025 07:00:00 GMT
• KalVista Pharmaceuticals Reports Strong Start for EKTERLY Launch TipRanks Thu, 11 Sep 2025 07:00:00 GMT
• KalVista Pharmaceuticals’ Earnings Call Highlights EKTERLY Success TipRanks Thu, 11 Sep 2025 07:00:00 GMT
• KalVista Pharmaceuticals (KALV) Misses Q1 Earnings Estimates GuruFocus Thu, 11 Sep 2025 07:00:00 GMT
• Earnings call transcript: KalVista Pharma surprises with Q1 FY2026 revenue Investing.com Thu, 11 Sep 2025 07:00:00 GMT
• Promising Outlook for KalVista Pharmaceuticals: Buy Rating Justified by Strong Launch Metrics and Strategic Initiatives for Ekterl... TipRanks Thu, 11 Sep 2025 07:00:00 GMT
• parkman healthcare partners llc buys shares of 753,752 kalvista pharmaceuticals, inc. $kalv MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
• promising market penetration and growth potential for kalvista pharmaceuticals’ ekterly TipRanks Thu, 11 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals, inc. $kalv shares purchased by invesco ltd. MarketBeat Thu, 11 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals fiscal q1 loss widens, posts net product revenue MarketScreener Thu, 11 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals inc (kalv) q1 2026 earnings call highlights: ekterly launch drives ... by gurufocus Investing.com Canada Thu, 11 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals (nasdaq:kalv) sets new 1-year high - here's why MarketBeat Wed, 10 Sep 2025 20:56:39 GMT
• kalvista pharmaceuticals (nasdaq:kalv) hits new 52-week high - here's what happened MarketBeat Wed, 10 Sep 2025 20:56:39 GMT
• kalvista pharmaceuticals, inc. $kalv shares bought by invesco ltd. MarketBeat Wed, 10 Sep 2025 19:10:05 GMT
• KalVista Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Benzinga Wed, 10 Sep 2025 07:00:00 GMT
• nuveen llc invests $431,000 in kalvista pharmaceuticals, inc. $kalv MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
• adage capital partners gp l.l.c. sells 24,000 shares of kalvista pharmaceuticals, inc. $kalv MarketBeat Wed, 10 Sep 2025 07:00:00 GMT
• kalvista pharma ceo palleiko sells $115k in shares by investing.com Investing.com Australia Wed, 10 Sep 2025 02:44:36 GMT
• 37,321 shares in kalvista pharmaceuticals, inc. $kalv bought by nuveen llc MarketBeat Wed, 10 Sep 2025 00:11:15 GMT
• adage capital partners gp l.l.c. has $3.19 million position in kalvista pharmaceuticals, inc. $kalv MarketBeat Tue, 09 Sep 2025 09:33:39 GMT
• adage capital partners gp l.l.c. sells 24,000 shares of kalvista pharmaceuticals, inc. $kalv MarketBeat Tue, 09 Sep 2025 09:33:39 GMT
• kalvista pharmaceuticals inc expected to post a loss of 95 cents a share - earnings preview TradingView Tue, 09 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals, inc. $kalv shares sold by rafferty asset management llc MarketBeat Tue, 09 Sep 2025 07:00:00 GMT
• is kalvista pharmaceuticals inc. subject to activist investor interest - m&a rumor & weekly setup with high roi potential beatles.ru Mon, 08 Sep 2025 21:49:57 GMT
• allostery investments lp decreases stake in kalvista pharmaceuticals, inc. $kalv MarketBeat Mon, 08 Sep 2025 19:30:00 GMT
• 753,752 shares in kalvista pharmaceuticals, inc. $kalv purchased by parkman healthcare partners llc MarketBeat Mon, 08 Sep 2025 12:08:39 GMT
• invesco ltd. grows stock position in kalvista pharmaceuticals, inc. $kalv MarketBeat Mon, 08 Sep 2025 10:11:34 GMT
• what analysts say about kalvista pharmaceuticals inc. stock - july 2025 rallies & daily profit maximizing tips beatles.ru Mon, 08 Sep 2025 08:47:08 GMT
• kalvista pharmaceuticals, inc. $kalv shares sold by vestal point capital lp MarketBeat Sun, 07 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals (nasdaq:kalv) trading up 5.8% - should you buy? MarketBeat Sun, 07 Sep 2025 07:00:00 GMT
• short interest data insights for kalvista pharmaceuticals inc. - 2025 top gainers & daily volume surge signals Newser Sat, 06 Sep 2025 18:56:27 GMT
• is kalvista pharmaceuticals inc. stock a smart retirement pick - weekly stock recap & reliable volume spike alerts خودرو بانک Sat, 06 Sep 2025 06:23:49 GMT
• aug rallies: what is kalvista pharmaceuticals inc. s 5 year growth outlook - 2025 big picture & capital protection trade alerts خودرو بانک Fri, 05 Sep 2025 22:07:09 GMT
• what analysts say about kalvista pharmaceuticals inc. stock - 2025 risk factors & breakout confirmation trade signals خودرو بانک Fri, 05 Sep 2025 21:58:46 GMT
• can kalvista pharmaceuticals inc. deliver consistent dividends - quarterly portfolio summary & long-term capital growth strategies... خودرو بانک Fri, 05 Sep 2025 20:33:11 GMT
• can technical indicators confirm kalvista pharmaceuticals inc.’s reversal - chart signals & safe entry point alerts Newser Fri, 05 Sep 2025 19:49:45 GMT
• kalvista pharmaceuticals inc. stock volume spike explained - gap down & real-time stock entry alerts Newser Fri, 05 Sep 2025 14:41:09 GMT
• is kalvista pharmaceuticals inc. building a consolidation base - 2025 earnings surprises & low risk entry point guides Newser Fri, 05 Sep 2025 14:34:30 GMT
• does kalvista pharmaceuticals (nasdaq:kalv) have a healthy balance sheet? 富途牛牛 Fri, 05 Sep 2025 12:12:47 GMT
• what macd and rsi say about kalvista pharmaceuticals inc. - 2025 major catalysts & ai powered buy/sell recommendations Newser Fri, 05 Sep 2025 10:27:11 GMT
• Is KalVista Pharmaceuticals (NASDAQ:KALV) A Risky Investment? simplywall.st Fri, 05 Sep 2025 07:00:00 GMT
• can volume confirm reversal in kalvista pharmaceuticals inc. - 2025 market trends & low drawdown trading techniques Newser Fri, 05 Sep 2025 06:49:51 GMT
• combining machine learning predictions for kalvista pharmaceuticals inc. - trend reversal & daily volume surge signals Newser Fri, 05 Sep 2025 03:39:54 GMT
• evaluating kalvista pharmaceuticals inc. with trendline analysis - market volume report & risk adjusted swing trade ideas Newser Fri, 05 Sep 2025 03:38:12 GMT
• can volume confirm reversal in kalvista pharmaceuticals inc. - 2025 risk factors & free long-term investment growth plans Newser Thu, 04 Sep 2025 22:57:55 GMT
• can kalvista pharmaceuticals inc. maintain sales growth - earnings growth summary & stepwise entry and exit trade signals خودرو بانک Thu, 04 Sep 2025 18:49:38 GMT
• combining machine learning predictions for kalvista pharmaceuticals inc. - long setup & free technical confirmation trade alerts Newser Thu, 04 Sep 2025 12:39:21 GMT
• what macd and rsi say about kalvista pharmaceuticals inc. - forecast cut & consistent profit trading strategies Newser Thu, 04 Sep 2025 11:05:18 GMT
• KalVista Pharmaceuticals to Provide Operational Update and Fiscal Quarter Financial Results on September 11, 2025 Yahoo Finance Thu, 04 Sep 2025 07:00:00 GMT
• KalVista Q1 Earnings On Deck - Will Sebetralstat's EU Nod Be The Catalyst It Needs? RTTNews Thu, 04 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4) Business Wire Thu, 04 Sep 2025 07:00:00 GMT
• russell investments group ltd. lowers stock holdings in kalvista pharmaceuticals, inc. $kalv MarketBeat Thu, 04 Sep 2025 07:00:00 GMT
• dafna capital management llc trims stake in kalvista pharmaceuticals, inc. $kalv MarketBeat Thu, 04 Sep 2025 07:00:00 GMT
• evaluating kalvista pharmaceuticals inc. with trendline analysis - weekly trend summary & technical entry and exit tips Newser Thu, 04 Sep 2025 06:49:53 GMT
• can technical indicators confirm kalvista pharmaceuticals inc.’s reversal - ceo change & ai driven price predictions Newser Thu, 04 Sep 2025 06:08:36 GMT
• institutional scanner results for kalvista pharmaceuticals inc. - wall street watch & high accuracy swing entry alerts Newser Thu, 04 Sep 2025 05:49:52 GMT
• applying elliott wave theory to kalvista pharmaceuticals inc. - weekly trade review & daily chart pattern signal reports Newser Thu, 04 Sep 2025 05:21:42 GMT
• short interest data insights for kalvista pharmaceuticals inc. - july 2025 action & community consensus picks Newser Thu, 04 Sep 2025 03:38:47 GMT
• what’s the recovery path for long term holders of kalvista pharmaceuticals inc. - 2025 volatility report & free weekly watchlist o... Newser Thu, 04 Sep 2025 00:07:56 GMT
• combining machine learning predictions for kalvista pharmaceuticals inc. - 2025 fundamental recap & weekly high momentum picks Newser Wed, 03 Sep 2025 14:43:17 GMT
• what is kalvista pharmaceuticals inc. s debt to equity ratio - dip buying & safe entry point identification خودرو بانک Wed, 03 Sep 2025 14:26:28 GMT
• what macd and rsi say about kalvista pharmaceuticals inc. - july 2025 catalysts & long-term capital growth strategies Newser Wed, 03 Sep 2025 10:59:08 GMT
• price action breakdown for kalvista pharmaceuticals inc. - jobs report & verified momentum stock ideas Newser Wed, 03 Sep 2025 08:40:04 GMT
• short interest data insights for kalvista pharmaceuticals inc. - july 2025 final week & daily profit focused stock screening Newser Wed, 03 Sep 2025 08:20:52 GMT
• is kalvista pharmaceuticals inc. building a consolidation base - quarterly profit report & fast entry momentum trade alerts Newser Wed, 03 Sep 2025 08:18:36 GMT
• can technical indicators confirm kalvista pharmaceuticals inc.’s reversal - dollar strength & high yield equity trading tips Newser Wed, 03 Sep 2025 07:21:13 GMT
• KalVista Pharmaceuticals Meets 80-Plus Relative Strength Rating Benchmark Investor's Business Daily Wed, 03 Sep 2025 07:00:00 GMT
• KalVista Pharmaceuticals: A Promising Investment with Ekterly’s Market Potential TipRanks Wed, 03 Sep 2025 07:00:00 GMT
• how high can kalvista pharmaceuticals inc. stock go - market growth review & weekly watchlist for hot stocks Newser Wed, 03 Sep 2025 06:41:18 GMT
• price momentum metrics for kalvista pharmaceuticals inc. explained - swing trade & weekly top performers watchlists Newser Wed, 03 Sep 2025 06:13:49 GMT
• chart based exit strategy for kalvista pharmaceuticals inc. - 2025 top decliners & ai driven stock reports Newser Wed, 03 Sep 2025 04:27:56 GMT
• how institutional ownership impacts kalvista pharmaceuticals inc. stock - 2025 top gainers & consistent profit alerts Newser Tue, 02 Sep 2025 23:40:49 GMT
• is kalvista pharmaceuticals inc. stock a smart retirement pick - earnings miss & weekly high potential stock alerts خودرو بانک Tue, 02 Sep 2025 21:59:42 GMT
• combining machine learning predictions for kalvista pharmaceuticals inc. - quarterly profit review & verified momentum watchlists Newser Tue, 02 Sep 2025 20:58:49 GMT
• what macd and rsi say about kalvista pharmaceuticals inc. - 2025 earnings surprises & community consensus trade alerts Newser Tue, 02 Sep 2025 15:23:44 GMT
• KALVISTA PHARMACEUTICALS Earnings Preview: Recent $KALV Insider Trading, Hedge Fund Activity, and More Quiver Quantitative Tue, 02 Sep 2025 07:00:00 GMT
• walleye capital llc sells 18,582 shares of kalvista pharmaceuticals, inc. $kalv MarketBeat Tue, 02 Sep 2025 07:00:00 GMT
• kalvista pharmaceuticals (kalv) to release earnings on thursday MarketBeat Tue, 02 Sep 2025 07:00:00 GMT
• can volume confirm reversal in kalvista pharmaceuticals inc. - 2025 analyst calls & entry point strategy guides Newser Tue, 02 Sep 2025 06:52:00 GMT
• chart based exit strategy for kalvista pharmaceuticals inc. - weekly trend report & ai based trade execution alerts Newser Tue, 02 Sep 2025 05:20:02 GMT
• kalvista pharmaceuticals inc. recovers — but is it sustainable getlinesfromresbyarray error: size == 0 강소기업뉴스 Mon, 01 Sep 2025 22:16:01 GMT
• price action breakdown for kalvista pharmaceuticals inc. - 2025 fundamental recap & weekly momentum stock picks Newser Mon, 01 Sep 2025 08:49:19 GMT
• analyzing recovery setups for kalvista pharmaceuticals inc. investors - trade volume report & technical entry and exit tips Newser Mon, 01 Sep 2025 05:18:35 GMT
• can technical indicators confirm kalvista pharmaceuticals inc.’s reversal - earnings performance report & low risk entry point tip... Newser Mon, 01 Sep 2025 03:54:33 GMT
• sentiment analysis tools applied to kalvista pharmaceuticals inc. - july 2025 volume & fast gaining stock reports Newser Mon, 01 Sep 2025 03:27:58 GMT
• price momentum metrics for kalvista pharmaceuticals inc. explained - earnings recap summary & weekly high return stock opportuniti... Newser Mon, 01 Sep 2025 02:00:16 GMT
• short interest data insights for kalvista pharmaceuticals inc. - trade performance summary & low drawdown investment ideas Newser Mon, 01 Sep 2025 00:54:25 GMT
• heatmap data shows high activity in kalvista pharmaceuticals inc. sector - 2025 pullback review & growth oriented trading recommen... beatles.ru Mon, 01 Sep 2025 00:23:37 GMT
• can volume confirm reversal in kalvista pharmaceuticals inc. - july 2025 setups & verified momentum stock watchlist Newser Mon, 01 Sep 2025 00:08:35 GMT
• can technical indicators confirm kalvista pharmaceuticals inc.’s reversal - july 2025 drop watch & smart allocation stock reports Newser Sun, 31 Aug 2025 21:09:57 GMT
• how to build a dashboard for kalvista pharmaceuticals inc. stock - weekly trade analysis & fast moving stock trade plans Newser Sun, 31 Aug 2025 20:43:42 GMT
• kalvista pharmaceuticals inc. stock volume spike explained - quarterly portfolio report & accurate buy signal alerts Newser Sun, 31 Aug 2025 20:22:34 GMT
• sentiment analysis tools applied to kalvista pharmaceuticals inc. - 2025 year in review & expert verified movement alerts Newser Sun, 31 Aug 2025 17:38:07 GMT
• price action breakdown for kalvista pharmaceuticals inc. - 2025 short interest & high return trade guides Newser Sun, 31 Aug 2025 17:33:40 GMT
• how high can kalvista pharmaceuticals inc. stock go - weekly market report & ai forecasted entry/exit points Newser Sun, 31 Aug 2025 12:41:59 GMT
• chart based exit strategy for kalvista pharmaceuticals inc. - market performance summary & ai forecasted entry and exit points Newser Sun, 31 Aug 2025 06:39:18 GMT
• how institutional ownership impacts kalvista pharmaceuticals inc. stock - july 2025 recap & capital protection trade alerts Newser Sun, 31 Aug 2025 06:33:28 GMT
• price momentum metrics for kalvista pharmaceuticals inc. explained - earnings recap summary & high conviction buy zone alerts Newser Sun, 31 Aug 2025 01:35:52 GMT
KalVista Pharmaceuticals, Inc(NASDAQ:KALV) 
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HA...
Website: http://www.kalvista.com
Founded: 2004
Full Time Employees: 56
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends